1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine and Nanobiotechnology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nanoparticles
1.2.3 Nanoshells
1.2.4 Nanotubes
1.2.5 Nanodevices
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nanomedicine and Nanobiotechnology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine and Nanobiotechnology Market Perspective (2018-2029)
2.2 Nanomedicine and Nanobiotechnology Growth Trends by Region
2.2.1 Global Nanomedicine and Nanobiotechnology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nanomedicine and Nanobiotechnology Historic Market Size by Region (2018-2023)
2.2.3 Nanomedicine and Nanobiotechnology Forecasted Market Size by Region (2024-2029)
2.3 Nanomedicine and Nanobiotechnology Market Dynamics
2.3.1 Nanomedicine and Nanobiotechnology Industry Trends
2.3.2 Nanomedicine and Nanobiotechnology Market Drivers
2.3.3 Nanomedicine and Nanobiotechnology Market Challenges
2.3.4 Nanomedicine and Nanobiotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine and Nanobiotechnology Players by Revenue
3.1.1 Global Top Nanomedicine and Nanobiotechnology Players by Revenue (2018-2023)
3.1.2 Global Nanomedicine and Nanobiotechnology Revenue Market Share by Players (2018-2023)
3.2 Global Nanomedicine and Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanomedicine and Nanobiotechnology Revenue
3.4 Global Nanomedicine and Nanobiotechnology Market Concentration Ratio
3.4.1 Global Nanomedicine and Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine and Nanobiotechnology Revenue in 2022
3.5 Nanomedicine and Nanobiotechnology Key Players Head office and Area Served
3.6 Key Players Nanomedicine and Nanobiotechnology Product Solution and Service
3.7 Date of Enter into Nanomedicine and Nanobiotechnology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine and Nanobiotechnology Breakdown Data by Type
4.1 Global Nanomedicine and Nanobiotechnology Historic Market Size by Type (2018-2023)
4.2 Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Type (2024-2029)
5 Nanomedicine and Nanobiotechnology Breakdown Data by Application
5.1 Global Nanomedicine and Nanobiotechnology Historic Market Size by Application (2018-2023)
5.2 Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nanomedicine and Nanobiotechnology Market Size (2018-2029)
6.2 North America Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023)
6.4 North America Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanomedicine and Nanobiotechnology Market Size (2018-2029)
7.2 Europe Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023)
7.4 Europe Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size (2018-2029)
8.2 Asia-Pacific Nanomedicine and Nanobiotechnology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2018-2023)
8.4 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanomedicine and Nanobiotechnology Market Size (2018-2029)
9.2 Latin America Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023)
9.4 Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size (2018-2029)
10.2 Middle East & Africa Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023)
10.4 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Nanomedicine and Nanobiotechnology Introduction
11.1.4 Abbott Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nanomedicine and Nanobiotechnology Introduction
11.2.4 GE Healthcare Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.2.5 GE Healthcare Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Nanomedicine and Nanobiotechnology Introduction
11.3.4 Johnson & Johnson Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Nanomedicine and Nanobiotechnology Introduction
11.4.4 Merck Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Nanomedicine and Nanobiotechnology Introduction
11.5.4 Pfizer Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 CombiMatrix
11.6.1 CombiMatrix Company Detail
11.6.2 CombiMatrix Business Overview
11.6.3 CombiMatrix Nanomedicine and Nanobiotechnology Introduction
11.6.4 CombiMatrix Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.6.5 CombiMatrix Recent Development
11.7 Celgene
11.7.1 Celgene Company Detail
11.7.2 Celgene Business Overview
11.7.3 Celgene Nanomedicine and Nanobiotechnology Introduction
11.7.4 Celgene Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.7.5 Celgene Recent Development
11.8 Mallinckrodt
11.8.1 Mallinckrodt Company Detail
11.8.2 Mallinckrodt Business Overview
11.8.3 Mallinckrodt Nanomedicine and Nanobiotechnology Introduction
11.8.4 Mallinckrodt Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.8.5 Mallinckrodt Recent Development
11.9 Sigma-Tau Pharmaceuticals
11.9.1 Sigma-Tau Pharmaceuticals Company Detail
11.9.2 Sigma-Tau Pharmaceuticals Business Overview
11.9.3 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Introduction
11.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.9.5 Sigma-Tau Pharmaceuticals Recent Development
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Detail
11.10.2 Teva Pharmaceutical Business Overview
11.10.3 Teva Pharmaceutical Nanomedicine and Nanobiotechnology Introduction
11.10.4 Teva Pharmaceutical Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.10.5 Teva Pharmaceutical Recent Development
11.11 Nanosphere
11.11.1 Nanosphere Company Detail
11.11.2 Nanosphere Business Overview
11.11.3 Nanosphere Nanomedicine and Nanobiotechnology Introduction
11.11.4 Nanosphere Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.11.5 Nanosphere Recent Development
11.12 UCB SA
11.12.1 UCB SA Company Detail
11.12.2 UCB SA Business Overview
11.12.3 UCB SA Nanomedicine and Nanobiotechnology Introduction
11.12.4 UCB SA Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023)
11.12.5 UCB SA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nanomedicine and Nanobiotechnology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Nanoparticles
Table 3. Key Players of Nanoshells
Table 4. Key Players of Nanotubes
Table 5. Key Players of Nanodevices
Table 6. Key Players of Others
Table 7. Global Nanomedicine and Nanobiotechnology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Nanomedicine and Nanobiotechnology Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Nanomedicine and Nanobiotechnology Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Nanomedicine and Nanobiotechnology Market Share by Region (2018-2023)
Table 11. Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Nanomedicine and Nanobiotechnology Market Share by Region (2024-2029)
Table 13. Nanomedicine and Nanobiotechnology Market Trends
Table 14. Nanomedicine and Nanobiotechnology Market Drivers
Table 15. Nanomedicine and Nanobiotechnology Market Challenges
Table 16. Nanomedicine and Nanobiotechnology Market Restraints
Table 17. Global Nanomedicine and Nanobiotechnology Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Nanomedicine and Nanobiotechnology Market Share by Players (2018-2023)
Table 19. Global Top Nanomedicine and Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine and Nanobiotechnology as of 2022)
Table 20. Ranking of Global Top Nanomedicine and Nanobiotechnology Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Nanomedicine and Nanobiotechnology Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicine and Nanobiotechnology Product Solution and Service
Table 24. Date of Enter into Nanomedicine and Nanobiotechnology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicine and Nanobiotechnology Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Type (2018-2023)
Table 28. Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Type (2024-2029)
Table 30. Global Nanomedicine and Nanobiotechnology Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Application (2018-2023)
Table 32. Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Application (2024-2029)
Table 34. North America Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2024-2029) & (US$ Million)
Table 49. Abbott Company Detail
Table 50. Abbott Business Overview
Table 51. Abbott Nanomedicine and Nanobiotechnology Product
Table 52. Abbott Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 53. Abbott Recent Development
Table 54. GE Healthcare Company Detail
Table 55. GE Healthcare Business Overview
Table 56. GE Healthcare Nanomedicine and Nanobiotechnology Product
Table 57. GE Healthcare Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 58. GE Healthcare Recent Development
Table 59. Johnson & Johnson Company Detail
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Nanomedicine and Nanobiotechnology Product
Table 62. Johnson & Johnson Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 63. Johnson & Johnson Recent Development
Table 64. Merck Company Detail
Table 65. Merck Business Overview
Table 66. Merck Nanomedicine and Nanobiotechnology Product
Table 67. Merck Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Pfizer Company Detail
Table 70. Pfizer Business Overview
Table 71. Pfizer Nanomedicine and Nanobiotechnology Product
Table 72. Pfizer Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. CombiMatrix Company Detail
Table 75. CombiMatrix Business Overview
Table 76. CombiMatrix Nanomedicine and Nanobiotechnology Product
Table 77. CombiMatrix Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 78. CombiMatrix Recent Development
Table 79. Celgene Company Detail
Table 80. Celgene Business Overview
Table 81. Celgene Nanomedicine and Nanobiotechnology Product
Table 82. Celgene Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 83. Celgene Recent Development
Table 84. Mallinckrodt Company Detail
Table 85. Mallinckrodt Business Overview
Table 86. Mallinckrodt Nanomedicine and Nanobiotechnology Product
Table 87. Mallinckrodt Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 88. Mallinckrodt Recent Development
Table 89. Sigma-Tau Pharmaceuticals Company Detail
Table 90. Sigma-Tau Pharmaceuticals Business Overview
Table 91. Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Product
Table 92. Sigma-Tau Pharmaceuticals Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 93. Sigma-Tau Pharmaceuticals Recent Development
Table 94. Teva Pharmaceutical Company Detail
Table 95. Teva Pharmaceutical Business Overview
Table 96. Teva Pharmaceutical Nanomedicine and Nanobiotechnology Product
Table 97. Teva Pharmaceutical Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 98. Teva Pharmaceutical Recent Development
Table 99. Nanosphere Company Detail
Table 100. Nanosphere Business Overview
Table 101. Nanosphere Nanomedicine and Nanobiotechnology Product
Table 102. Nanosphere Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 103. Nanosphere Recent Development
Table 104. UCB SA Company Detail
Table 105. UCB SA Business Overview
Table 106. UCB SA Nanomedicine and Nanobiotechnology Product
Table 107. UCB SA Revenue in Nanomedicine and Nanobiotechnology Business (2018-2023) & (US$ Million)
Table 108. UCB SA Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicine and Nanobiotechnology Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Nanomedicine and Nanobiotechnology Market Share by Type: 2022 VS 2029
Figure 3. Nanoparticles Features
Figure 4. Nanoshells Features
Figure 5. Nanotubes Features
Figure 6. Nanodevices Features
Figure 7. Others Features
Figure 8. Global Nanomedicine and Nanobiotechnology Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Nanomedicine and Nanobiotechnology Market Share by Application: 2022 VS 2029
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Nanomedicine and Nanobiotechnology Report Years Considered
Figure 14. Global Nanomedicine and Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Nanomedicine and Nanobiotechnology Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Nanomedicine and Nanobiotechnology Market Share by Region: 2022 VS 2029
Figure 17. Global Nanomedicine and Nanobiotechnology Market Share by Players in 2022
Figure 18. Global Top Nanomedicine and Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine and Nanobiotechnology as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Nanomedicine and Nanobiotechnology Revenue in 2022
Figure 20. North America Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Nanomedicine and Nanobiotechnology Market Share by Country (2018-2029)
Figure 22. United States Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Nanomedicine and Nanobiotechnology Market Share by Country (2018-2029)
Figure 26. Germany Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Nanomedicine and Nanobiotechnology Market Share by Region (2018-2029)
Figure 34. China Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Nanomedicine and Nanobiotechnology Market Share by Country (2018-2029)
Figure 42. Mexico Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Nanomedicine and Nanobiotechnology Market Share by Country (2018-2029)
Figure 46. Turkey Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 49. GE Healthcare Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 53. CombiMatrix Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 54. Celgene Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 55. Mallinckrodt Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 56. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 58. Nanosphere Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 59. UCB SA Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
